These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32180532)

  • 41. Application of Immunocompetent Microphysiological Systems in Drug Development: Current Perspective and Recommendations.
    Wang X; Kopec AK; Collinge M; David R; Grant C; Hardwick RN; Navratil A; Patel N; Rowan W; Marshall N
    ALTEX; 2022 Aug; 40(2):314–336. PubMed ID: 36044561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
    Yamazaki D
    Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microphysiological systems for human aging research.
    Park S; Laskow TC; Chen J; Guha P; Dawn B; Kim DH
    Aging Cell; 2024 Mar; 23(3):e14070. PubMed ID: 38180277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in microfluidic in vitro systems for neurological disease modeling.
    Holloway PM; Willaime-Morawek S; Siow R; Barber M; Owens RM; Sharma AD; Rowan W; Hill E; Zagnoni M
    J Neurosci Res; 2021 May; 99(5):1276-1307. PubMed ID: 33583054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of microphysiological systems for nonclinical evaluation of cell therapies.
    Candarlioglu PL; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan KA; Fellows MD; Pointon A; Kojala K
    ALTEX; 2024; 41(3):469-484. PubMed ID: 38746991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microphysiological Systems to Assess Nonclinical Toxicity.
    Van Ness KP; Chang SY; Weber EJ; Zumpano D; Eaton DL; Kelly EJ
    Curr Protoc Toxicol; 2017 Aug; 73():14.18.1-14.18.28. PubMed ID: 28777442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Academic User View: Organ-on-a-Chip Technology.
    Busek M; Aizenshtadt A; Amirola-Martinez M; Delon L; Krauss S
    Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineered skeletal muscles for disease modeling and drug discovery.
    Wang J; Khodabukus A; Rao L; Vandusen K; Abutaleb N; Bursac N
    Biomaterials; 2019 Nov; 221():119416. PubMed ID: 31419653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A high-throughput microfluidic microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating flow conditions.
    Tan K; Keegan P; Rogers M; Lu M; Gosset JR; Charest J; Bale SS
    Lab Chip; 2019 Apr; 19(9):1556-1566. PubMed ID: 30855604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction of pancreas-muscle-liver microphysiological system (MPS) for reproducing glucose metabolism.
    Lee DW; Lee SH; Choi N; Sung JH
    Biotechnol Bioeng; 2019 Dec; 116(12):3433-3445. PubMed ID: 31429925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems.
    Kurokawa YK; Yin RT; Shang MR; Shirure VS; Moya ML; George SC
    Tissue Eng Part C Methods; 2017 Aug; 23(8):474-484. PubMed ID: 28622076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges.
    Sakolish CM; Esch MB; Hickman JJ; Shuler ML; Mahler GJ
    EBioMedicine; 2016 Mar; 5():30-9. PubMed ID: 27077109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
    Edington CD; Chen WLK; Geishecker E; Kassis T; Soenksen LR; Bhushan BM; Freake D; Kirschner J; Maass C; Tsamandouras N; Valdez J; Cook CD; Parent T; Snyder S; Yu J; Suter E; Shockley M; Velazquez J; Velazquez JJ; Stockdale L; Papps JP; Lee I; Vann N; Gamboa M; LaBarge ME; Zhong Z; Wang X; Boyer LA; Lauffenburger DA; Carrier RL; Communal C; Tannenbaum SR; Stokes CL; Hughes DJ; Rohatgi G; Trumper DL; Cirit M; Griffith LG
    Sci Rep; 2018 Mar; 8(1):4530. PubMed ID: 29540740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Organ-on-a-chip models for elucidating the cellular biology of infectious diseases.
    Yokoi F; Deguchi S; Takayama K
    Biochim Biophys Acta Mol Cell Res; 2023 Aug; 1870(6):119504. PubMed ID: 37245539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
    Donoghue L; Nguyen KT; Graham C; Sethu P
    Micromachines (Basel); 2021 Jan; 12(2):. PubMed ID: 33525451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Programming microphysiological systems for children's health protection.
    Knudsen TB; Klieforth B; Slikker W
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1586-1592. PubMed ID: 28658972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Standalone cell culture microfluidic device-based microphysiological system for automated cell observation and application in nephrotoxicity tests.
    Kimura H; Nakamura H; Goto T; Uchida W; Uozumi T; Nishizawa D; Shinha K; Sakagami J; Doi K
    Lab Chip; 2024 Jan; 24(3):408-421. PubMed ID: 38131210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility.
    Pamies D; Ekert J; Zurich MG; Frey O; Werner S; Piergiovanni M; Freedman BS; Keong Teo AK; Erfurth H; Reyes DR; Loskill P; Candarlioglu P; Suter-Dick L; Wang S; Hartung T; Coecke S; Stacey GN; Wagegg BA; Dehne EM; Pistollato F; Leist M
    Stem Cell Reports; 2024 May; 19(5):604-617. PubMed ID: 38670111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue Chips to aid drug development and modeling for rare diseases.
    Low LA; Tagle DA
    Expert Opin Orphan Drugs; 2016; 4(11):1113-1121. PubMed ID: 28626620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.